ABT:NYE-Abbott Laboratories (USD)

EQUITY | Medical Devices | New York Stock Exchange

Last Closing

USD 132.13

Change

+1.95 (+1.50)%

Market Cap

USD 56.45B

Volume

3.81M

Analyst Target

USD 115.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Abbott Laboratories discovers, develops, manufactures and sells health care products. Its products include branded generic pharmaceuticals manufactured internationally, marketed and sold outside the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
MDT Medtronic PLC

+0.94 (+1.08%)

USD 116.46B
SEMHF Siemens Healthineers AG

N/A

USD 67.08B
STE STERIS plc

-0.60 (-0.27%)

USD 21.55B
ZBH Zimmer Biomet Holdings Inc

+0.29 (+0.28%)

USD 20.01B
GMED Globus Medical

+0.03 (+0.04%)

USD 11.43B
SNN Smith & Nephew SNATS Inc

+0.10 (+0.39%)

USD 11.17B
PEN Penumbra Inc

-0.64 (-0.21%)

USD 10.31B
BIO Bio-Rad Laboratories Inc

+1.90 (+0.67%)

USD 10.09B
BIO-B Bio-Rad Laboratories Inc

N/A

USD 9.59B
GKOS Glaukos Corp

-3.22 (-2.01%)

USD 8.45B

ETFs Containing ABT

UMDV:SW iShares US Medical Device.. 16.05 % 0.00 %

N/A

N/A
EDOC:AU BetaShares Digital Health.. 7.78 % 0.00 %

N/A

N/A
HART IQ Healthy Hearts ETF 5.27 % 0.00 %

+0.11 (+0%)

USD 9.76M
GDOC Goldman Sachs ETF Trust 5.11 % 0.00 %

+0.25 (+0%)

USD 0.02B
LIFE-U:CA Evolve Global Healthcare .. 5.05 % 0.00 %

+0.26 (+0%)

N/A
XGEN:XETRA 4.68 % 0.00 %

N/A

N/A
XDG3:XETRA 4.61 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.35 % 0.00 %

+0.03 (+0%)

N/A
XLV Health Care Select Sector.. 4.25 % 0.13 %

+0.82 (+0%)

USD 37.71B
QLTY The 2023 ETF Series Trust.. 4.13 % 0.00 %

-0.05 (0%)

USD 1.59B
SXLV:SW SPDR S&P U.S. Health Care.. 3.90 % 0.00 %

+0.56 (+0%)

N/A
IUAE:CA Invesco S&P US Dividend A.. 3.61 % 0.00 %

-0.01 (0%)

CAD 1.22M
DRUG:AU BetaShares Global Healthc.. 3.59 % 0.00 %

+0.03 (+0%)

USD 0.17B
WELG:XETRA 3.46 % 0.00 %

N/A

N/A
WELS:XETRA 3.46 % 0.00 %

N/A

N/A
XUHC:SW 3.38 % 0.00 %

N/A

N/A
FOHW:XETRA 3.37 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.36 % 0.00 %

+0.11 (+0%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.36 % 0.00 %

+0.15 (+0%)

N/A
SPMV Invesco S&P 500 Minimum V.. 3.14 % 0.00 %

-0.03 (0%)

USD 5.30M
XWHS:LSE Xtrackers MSCI World Heal.. 2.92 % 0.00 %

+0.17 (+0%)

USD 2.68B
HEAL:CA 2.82 % 0.00 %

N/A

N/A
WHEA:SW SPDR MSCI World Health Ca.. 2.73 % 0.00 %

N/A

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.13 % 0.00 %

-0.02 (0%)

N/A
XHE SPDR® S&P Health Care Eq.. 2.08 % 0.35 %

-0.64 (0%)

USD 0.20B
MFUT MFUT 1.94 % 0.00 %

-0.12 (0%)

USD 0.02B
RSPH Invesco S&P 500 Equal Wei.. 1.73 % 0.00 %

+0.16 (+0%)

USD 0.85B
HYLG Global X Funds - Global X.. 1.58 % 0.00 %

N/A

N/A
DFUV Dimensional US Marketwide.. 1.32 % 0.00 %

-0.25 (0%)

USD 11.61B
RSPE Invesco Exchange-Traded F.. 0.63 % 0.00 %

-0.04 (0%)

USD 0.02B
CURE Direxion Daily Healthcare.. 0.00 % 1.06 %

+1.85 (+0%)

USD 0.19B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

+0.23 (+0%)

USD 2.77B
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.36 (+0%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
PJP Invesco Dynamic Pharmaceu.. 0.00 % 0.56 %

+0.26 (+0%)

N/A
QDYN 0.00 % 0.37 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

-0.15 (0%)

USD 5.21B
VALQ American Century STOXX U... 0.00 % 0.29 %

-0.24 (0%)

USD 0.24B
RWDC 0.00 % 0.00 %

N/A

N/A
GDNA 0.00 % 0.00 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

-0.14 (0%)

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

-0.14 (0%)

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.50 (+0%)

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+1.25 (+0%)

N/A
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

+0.23 (+0%)

CAD 0.56B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

+0.12 (+0%)

CAD 0.22B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+4.13 (+0%)

N/A
ISDU:LSE iShares MSCI USA Islamic .. 0.00 % 0.00 %

+0.15 (+0%)

USD 0.25B
ISUS:LSE iShares MSCI USA Islamic .. 0.00 % 0.00 %

-20.50 (0%)

USD 0.24B
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

+0.10 (+0%)

USD 2.29B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.44 (+0%)

N/A
XGDD:LSE Xtrackers - Stoxx Global .. 0.00 % 0.00 %

+0.13 (+0%)

N/A
XGSD:LSE Xtrackers Stoxx Global Se.. 0.00 % 0.00 %

-2.50 (0%)

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+18.00 (+0%)

USD 0.65B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

+0.54 (+0%)

USD 0.65B
DXSB:F 0.00 % 0.00 %

N/A

N/A
QDVG:F 0.00 % 0.00 %

N/A

N/A
XDWH:F 0.00 % 0.00 %

N/A

N/A
XUHC:F 0.00 % 0.00 %

N/A

N/A
ZPDH:F 0.00 % 0.00 %

N/A

N/A
2B78:XETRA 0.00 % 0.00 %

N/A

N/A
DXSB:XETRA 0.00 % 0.00 %

N/A

N/A
QDVG:XETRA 0.00 % 0.00 %

N/A

N/A
XDWH:XETRA 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA 0.00 % 0.00 %

N/A

N/A
ZPDH:XETRA 0.00 % 0.00 %

N/A

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+0.49 (+0%)

USD 1.43B
BMED BlackRock Future Health E.. 0.00 % 0.00 %

+0.10 (+0%)

USD 3.22M
FUD-A:CA 0.00 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

+0.02 (+0%)

CAD 0.08B
2B78:F 0.00 % 0.00 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 0.00 % 0.00 %

+0.01 (+0%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.82% 74% C 93% A
Dividend Return 0.52% 100% F 29% F
Total Return 17.34% 74% C 94% A
Trailing 12 Months  
Capital Gain 12.10% 61% D- 61% D-
Dividend Return 1.90% 71% C- 32% F
Total Return 14.00% 61% D- 59% D-
Trailing 5 Years  
Capital Gain 51.09% 71% C- 72% C
Dividend Return 10.97% 88% B+ 35% F
Total Return 62.06% 79% B- 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 2.25% 45% F 42% F
Dividend Return 3.69% 45% F 38% F
Total Return 1.44% 75% C 35% F
Risk Return Profile  
Volatility (Standard Deviation) 19.90% 90% A- 54% F
Risk Adjusted Return 18.57% 55% F 33% F
Market Capitalization 56.45B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 43.70 90% 52%
Price/Book Ratio 5.58 31% 18%
Price / Cash Flow Ratio 30.56 22% 10%
Price/Free Cash Flow Ratio 25.16 26% 13%
Management Effectiveness  
Return on Equity 14.84% 96% 75%
Return on Invested Capital 10.37% 92% 67%
Return on Assets 6.49% 96% 83%
Debt to Equity Ratio 35.23% 63% 69%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.